Skip to main content

Main menu

  • Home
  • Articles
    • Current issue
    • Archive
  • About
    • Journal information
    • Editorial board
    • Press office
    • Reviewers
    • Permissions and reprints
    • Advertising
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS author centre
  • For readers
    • Alerts
    • Subjects
    • RSS
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Articles
    • Current issue
    • Archive
  • About
    • Journal information
    • Editorial board
    • Press office
    • Reviewers
    • Permissions and reprints
    • Advertising
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS author centre
  • For readers
    • Alerts
    • Subjects
    • RSS
  • Subscriptions

Pneumococcal urinary antigen test use in diagnosis and treatment of pneumonia in seven Utah hospitals

Devin M. West, Lindsay M. McCauley, Jeffrey S. Sorensen, Al R. Jephson, Nathan C. Dean
ERJ Open Research 2016 2: 00011-2016; DOI: 10.1183/23120541.00011-2016
Devin M. West
Dept of Medicine, Intermountain Medical Centre, Salt Lake City, UT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lindsay M. McCauley
Division of Pulmonary and Critical Care Medicine, Intermountain Medical Centre, Salt Lake City, UT, USADivision of Respiratory, Critical Care, and Occupational Medicine, Dept of Internal Medicine, University of Utah, Salt Lake City, UT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey S. Sorensen
Division of Pulmonary and Critical Care Medicine, Intermountain Medical Centre, Salt Lake City, UT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Al R. Jephson
Division of Pulmonary and Critical Care Medicine, Intermountain Medical Centre, Salt Lake City, UT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan C. Dean
Division of Pulmonary and Critical Care Medicine, Intermountain Medical Centre, Salt Lake City, UT, USADivision of Respiratory, Critical Care, and Occupational Medicine, Dept of Internal Medicine, University of Utah, Salt Lake City, UT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Nathan.Dean@imail.org
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Tables
  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Study population: seven emergency departments. UAT: urine antigen test; CAP: community-acquired pneumonia; HCAP: healthcare-associated pneumonia; ICU: intensive care unit.

  • FIGURE 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2

    Percentage of positive results by pathogen among study patients with identified pathogens. “Other” includes respiratory viruses, Stenotrophomonas, Prevotella, Peptostreptococcus and other Streptococcal species.

  • FIGURE 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3

    Changes in antibiotic therapy among patients with positive Streptococcus urinary antigen tests.

Tables

  • Figures
  • TABLE 1

    Clinical parameters for community-acquired pneumonia patients stratified by whether a urine antigen test was obtained.

    VariableUrinary antigen testp-value
    Obtained (n=931)Not obtained (n=1365)
    Age years63 (50–76)68 (51–81)<0.001
    Male458 (49.1)622 (45.5)0.10
    Intensive care unit486 (52.2)430 (31.5)<0.001
    PaO2/FiO2260.5 (202.4–319.1)269.5 (226.2–319.1)<0.001
    Pleural effusion134 (14.4)229 (16.8)0.14
    eCURB0.03 (0.014–0.08)0.028 (0.014–0.072)0.13
    sCAP minor2 (1–3)2 (1–2)0.001
    CURB-65 score0.28
     0260 (27.9)352 (25.7)
     1273 (29.3)428 (31.3)0.32
     2285 (30.6)426 (31.2)0.8
     397 (10.4)143 (10.5)1
     416 (1.7)12 (0.9)0.11
     504 (0.3)0.15
    • Data are presented as n (%) or median (interquartile range), unless otherwise stated. sCAP minor is the number of minor criteria for severe community-acquired pneumonia from the Infectious Diseases Society of America/American Thoracic Society 2007 community-acquired pneumonia guidelines 2007 and eCURB is the validated electronic version of CURB-65 (confusion, blood urea, respiratory rate, blood pressure, age 65 years) with weighted, continuous variables yielding a point estimate for 30-day mortality [13, 14]. PaO2: arterial oxygen tension; FiO2: fraction of inspired oxygen.

  • TABLE 2

    Clinical parameters for healthcare-associated pneumonia patients, stratified by whether a urine antigen test was obtained

    VariableUrinary antigen testp-value
    Obtained (n=179)Not obtained (n=362)
    Age years68 (55–80)70 (57–81)0.47
    Male76 (42.5)184 (50.8)0.08
    Intensive care unit99 (55.3)168 (46.4)0.06
    PaO2/FiO2248.2 (191.9–303.8)252.2 (203.0–337.6)0.20
    Pleural effusion50 (27.9)108 (29.8)0.72
    eCURB0.043 (0.019–0.134)0.047 (0.019–0.116)0.94
    sCAP minor2 (1–3)2 (1–3)0.64
    CURB-65 score
     030 (16.8)55 (15.2)0.73
     157 (31.8)106 (29.3)0.61
     255 (30.7)132 (36.5)0.22
     329 (16.2)55 (15.2)0.86
     47 (3.9)13 (3.6)1
     51 (0.6)1 (0.3)0.55
    • Data are presented as n (%) or median (interquartile range), unless otherwise stated. sCAP minor is the number of minor criteria for severe community-acquired pneumonia from the Infectious Diseases Society of America/American Thoracic Society 2007 community-acquired pneumonia guidelines 2007 and eCURB is the validated electronic version of CURB-65 (confusion, blood urea, respiratory rate, blood pressure, age 65 years) with weighted, continuous variables yielding a point estimate for 30-day mortality [13, 14]. PaO2: arterial oxygen tension; FiO2: fraction of inspired oxygen.

  • TABLE 3

    Clinical parameters for patients with a positive UAT, stratified by antibiotic therapy

    VariableAntibiotic therapy
    No change (n=38)De-escalation (n=76)Targeted (n=20)
    Age years58.5 (49.25–75)63 (50.5–74.25)57.5 (46.75–70.25)
    Male18 (47.4)37 (48.7)10 (50)
    Intensive care unit28 (73.7)48 (63.2)12 (60)
    PaO2/FiO2217.2 (178.4–274.8)252.2 (204.9–303.8)303.8 (214.5–360.5)
    Pleural effusion3 (7.9)12 (15.8)1 (5)
    eCURB0.053 (0.023–0.162)0.04 (0.019–0.082)0.028 (0.015–0.054)
    sCAP minor3 (2–3)2 (1–3)1 (0.75–2)
    CURB-65 score
     06 (15.8)12 (15.8)7 (35)
     110 (26.3)25 (32.9)8 (40)
     216 (42.1)30 (39.5)5 (25)
     36 (15.8)7 (9.2)0
     402 (2.6)0
     5000
    • Data are presented as n (%) or median (interquartile range), unless otherwise stated. sCAP minor is the number of minor criteria for severe community-acquired pneumonia from the Infectious Diseases Society of America/American Thoracic Society 2007 community-acquired pneumonia guidelines 2007 and eCURB is the validated electronic version of CURB-65 (confusion, blood urea, respiratory rate, blood pressure, age 65 years) with weighted, continuous variables yielding a point estimate for 30-day mortality [13, 14]. PaO2: arterial oxygen tension; FiO2: fraction of inspired oxygen.

PreviousNext
Back to top
Vol 2 Issue 4 Table of Contents
ERJ Open Research: 2 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pneumococcal urinary antigen test use in diagnosis and treatment of pneumonia in seven Utah hospitals
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Pneumococcal urinary antigen test use in diagnosis and treatment of pneumonia in seven Utah hospitals
Devin M. West, Lindsay M. McCauley, Jeffrey S. Sorensen, Al R. Jephson, Nathan C. Dean
ERJ Open Research Oct 2016, 2 (4) 00011-2016; DOI: 10.1183/23120541.00011-2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pneumococcal urinary antigen test use in diagnosis and treatment of pneumonia in seven Utah hospitals
Devin M. West, Lindsay M. McCauley, Jeffrey S. Sorensen, Al R. Jephson, Nathan C. Dean
ERJ Open Research Oct 2016, 2 (4) 00011-2016; DOI: 10.1183/23120541.00011-2016
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Acknowledgement
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Research priorities for respiratory nursing
  • Predicting pulmonary tuberculosis in immigrants
  • Early diagnosis from NBS maximises survival in severe CF
Show more Original articles

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Collections
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Fax: +44 114 266 5064
Email: info@ersj.org.uk

ISSN

Online ISSN: 2312-0541

Copyright © 2018 by the European Respiratory Society